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Abstract
Influenza viruses are causative agents of an acute febrile respiratory disease called influenza (commonly known as “flu”) and belong to the
Orthomyxoviridae family. These viruses possess segmented, negative stranded RNA genomes (vRNA) and are enveloped, usually spherical
and bud from the plasma membrane (more specifically, the apical plasma membrane of polarized epithelial cells). Complete virus particles,
therefore, are not found inside infected cells. Virus particles consist of three major subviral components, namely the viral envelope, matrix
protein (M1), and core (viral ribonucleocapsid [vRNP]). The viral envelope surrounding the vRNP consists of a lipid bilayer containing spikes
composed of viral glycoproteins (HA, NA, and M2) on the outer side and M1 on the inner side. Viral lipids, derived from the host plasma
membrane, are selectively enriched in cholesterol and glycosphingolipids. M1 forms the bridge between the viral envelope and the core. The
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ciral core consists of helical vRNP containing vRNA (minus strand) and NP along with minor amounts of NEP and polymerase complex (PA,
B1, and PB2). For viral morphogenesis to occur, all three viral components, namely the viral envelope (containing lipids and transmembrane
roteins), M1, and the vRNP must be brought to the assembly site, i.e. the apical plasma membrane in polarized epithelial cells. Finally, buds
ust be formed at the assembly site and virus particles released with the closure of buds.
Transmembrane viral proteins are transported to the assembly site on the plasma membrane via the exocytic pathway. Both HA and NA
ossess apical sorting signals and use lipid rafts for cell surface transport and apical sorting. These lipid rafts are enriched in cholesterol,
lycosphingolipids and are relatively resistant to neutral detergent extraction at low temperature. M1 is synthesized on free cytosolic polyri-
osomes. vRNPs are made inside the host nucleus and are exported into the cytoplasm through the nuclear pore with the help of M1 and
EP. How M1 and vRNPs are directed to the assembly site on the plasma membrane remains unclear. The likely possibilities are that they
se a piggy-back mechanism on viral glycoproteins or cytoskeletal elements. Alternatively, they may possess apical determinants or diffuse
o the assembly site, or a combination of these pathways. Interactions of M1 with M1, M1 with vRNP, and M1 with HA and NA facilitate
oncentration of viral components and exclusion of host proteins from the budding site. M1 interacts with the cytoplasmic tail (CT) and
ransmembrane domain (TMD) of glycoproteins, and thereby functions as a bridge between the viral envelope and vRNP.
Lipid rafts function as microdomains for concentrating viral glycoproteins and may serve as a platform for virus budding. Virus bud formation
equires membrane bending at the budding site. A combination of factors including concentration of and interaction among viral components,
ncreased viscosity and asymmetry of the lipid bilayer of the lipid raft as well as pulling and pushing forces of viral and host components are
ikely to cause outward curvature of the plasma membrane at the assembly site leading to bud formation. Eventually, virus release requires
ompletion of the bud due to fusion of the apposing membranes, leading to the closure of the bud, separation of the virus particle from thehost plasma membrane and release of the virus particle into the extracellular environment. Among the viral components, M1 contains an L
domain motif and plays a critical role in budding. Bud completion requires not only viral components but also host components. However,
how host components facilitate bud completion remains unclear. In addition to bud completion, influenza virus requires NA to release virus
particles from sialic acid residues on the cell surface and spread from cell to cell. Elucidation of both viral and host factors involved in viral
morphogenesis and budding may lead to the development of drugs interfering with the steps of viral morphogenesis and in disease progression.
© 2004 Elsevier B.V. All rights reserved.
Keywords: Influenza; Matrix protein; Viral ribonucleocapsid; Virus budding; Virus assembly
∗ Corresponding author. Fax: +1 310 206 3865.
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1. Introduction
Assembly and budding of virus particles are the last but
critically important steps in the virus life cycle for both the
0168-1702/$ – see front matter © 2004 Elsevier B.V. All rights reserved.
doi:10.1016/j.virusres.2004.08.012
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survival of the virus as well as its disease-producing abil-
ity in the host. Without completion of these two steps, in-
fected cells will undergo abortive infectious cycles without
releasing the complete virus particles. Specific host or tissue
cells may provide restrictions at multiple steps of the virus
life cycle including binding, entry, uncoating, synthesis and
transport of viral components as well as assembly and bud-
ding. Each of these steps is an important target for antiviral
prophylaxis and therapy. Furthermore, since a host is usu-
ally infected at a very low multiplicity of infection (MOI), an
efficient multicycle replication including virus release and
infection of new cells is obligatory for virus survival and
pathogenesis. In addition, the site of virus budding may de-
termine, at least partially, the nature of viral diseases. For
example, most viruses causing viremia and systemic dis-
ease usually bud from the basolateral surface or cause cell-
to-cell transmission by cell fusion forming heterokaryons.
These viruses are usually pantropic and can infect multiple
internal organs. On the other hand, viruses like influenza
virus, which bud apically and cannot cause cell-to-cell fu-
sion, are usually restricted to lungs and are pneumotropic in
mammals.
Influenza viruses are negative stranded, segmented, en-
veloped RNA viruses containing helical ribonucleocapsid
(also called viral ribonucleoprotein [vRNP]) and belong to
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(for review, see Elton et al., 2002; Portela and Digard,
2002).
Influenza virus particles bind to cell surface sialic acid,
ubiquitously present on glycoproteins or glycolipids. The
specificity of the sialic acid (2,3-linked or2,6-linked sialic
acid) and preferred binding of a particular strain of influenza
virus to a specific sialic acid receptor are important determi-
nants for species-specific restriction of influenza viruses (for
review, see Matrosovich and Klenk, 2003).
During the infectious cycle, virus particles, bound to cell
surface sialic acid, are internalized by receptor-mediated en-
docytosis and viruses possessing cleaved HA undergo fu-
sion with the endosomal membrane (for review, see Skehel
and Wiley, 2000; Stegmann, 2000) at low pH (pH ∼5.0).
Cleavage of HA is an absolute requirement for infectivity
and the nature of the HA cleavage site is an important viru-
lence determinant for influenza viruses. Cleavage efficiency
of HA varies depending on the presence of single or multi-
ple basic residues at the cleavage site of HA1 and HA2 and
the plasminogen binding ability of NA. Viruses containing
HA with a single positive charge at the cleavage site can be
cleaved by specific enzymes such as tryptase Clara present
in the lungs, whereas HA containing multiple basic residues
at the cleavage site are cleaved ubiquitously by proteases
(for review, see Kido et al., 1999a). WSN NA binds plas-
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rhe Orthomyxoviridae family (Lamb and Krug, 2001). Virus
articles are usually spherical and approximately 100 nm in
iameter (Fujiyoshi et al., 1994). The viral envelope consists
f a lipid bilayer containing transmembrane proteins on the
utside and matrix protein (M1) on the inside. Lipids are
erived from the host plasma membrane but are selectively
nriched in cholesterol and glycosphingolipids (Scheiffele
t al., 1999; Zhang et al., 2000). Three transmembrane en-
elope proteins (hemagglutinin [HA], neuraminidase [NA],
nd M2 [ion channel]) are anchored in the lipid bilayer of
he viral envelope. HA, a type I transmembrane protein, is a
omotrimer and is the major envelope protein (∼80%) form-
ng the spikes. HA provides the receptor-binding site and
licits neutralizing antibodies. Cleavage of HA is essential
or fusion and virus infectivity. NA, a type II transmembrane
rotein, is present as a homotetramer on the viral envelope.
A removes the cell surface receptor (sialic acid) and is crit-
cal for the release of virus particles from the cell surface
nd spread of virus. M2, a type III transmembrane protein, is
minor protein component (only 16–20 molecules/virion)
f the viral envelope. M2 is a homotetramer, functions
s an ion channel (for review, see Lear, 2003; Wu and
oth, 2003), and is crucial during uncoating for dissociat-
ng the vRNP from M1 in the early phase of the infectious
ycle.
The viral core consists of helical ribonucleocapsids
i.e. vRNP) containing vRNA (negative stranded) and NP
long with minor amounts of the nuclear export protein
NEP) (formerly called non-structural protein NS2) and
hree polymerase (3P) proteins (PB1, PB2, PA) which
orm the viral RNA polymerase complex (3P complex)inogen which when converted to plasmin can cleave HA
ven with a single basic residue (Goto and Kawaoka, 1998).
n the acid pH of the endosome, the cleaved HA undergoes
onformational changes releasing the NH2 terminal fusion
eptide of HA2 and causing fusion of viral and endosomal
embranes (for review, see Colman and Lawrence, 2003).
irus particles containing uncleaved HA can bind and be en-
ocytosed but cannot undergo fusion and are therefore non-
nfectious. The M2 ion channel opens up in the acidic pH of
he endosome, acidifies the internal virion core, and thereby
acilitates the release of vRNP from M1 into the cell cy-
oplasm. M1-free vRNP is then imported into the nucleus
hrough nuclear pores using nuclear transport signals of NP
Neumann et al., 2000). Inside the nucleus, vRNP undergoes
ranscription (mRNA synthesis) and replication (complete
ositive-sense complementary RNA [cRNA], vRNA [minus
trands], and vRNP synthesis) (for review, see Elton et al.,
002; Portela and Digard, 2002). Progeny vRNPs, made in-
ide the nucleus, are exported out of the nucleus into the
ytoplasm with the help of M1 and NEP (Chen and Krug,
000). Eventually, the envelope proteins (HA, NA, M2), ma-
rix protein (M1) and vRNP (containing vRNA minus-strand,
P, 3P proteins, and NEP) are transported to the assembly
ite on the plasma membrane where virus particles bud and
re released into the outside environment. This review deals
ith the processes involved in assembly and morphogene-
is of influenza viruses including vRNP exit from the nu-
leus, sorting, and transport of subviral components to the
ssembly site, interaction among the viral components as well
s the process of bud formation, bud completion, and virus
elease.
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2. Steps involved in the assembly and morphogenesis
of influenza virus
Morphogenesis of influenza virus is a complex multi-step
process, which involves not only nucleocapsid (vRNP) for-
mation but also envelopment of the nucleocapsid and release
of viral particles into the external environment. Assembly
and morphogenesis of influenza virus require a number of
obligatory steps: firstly, all viral (or subviral) components
must be directed and brought to the assembly site, i.e. the
plasma membrane in non-polarized cells or the apical plasma
membrane in polarized epithelial cells. Secondly, all viral
components must interact in an orderly fashion to assemble
into infectious virions. Thirdly, interaction and concentra-
tion of subviral components at the assembly site must initi-
ate bud formation, i.e. an outward curvature of the plasma
membrane. Finally, apposing membranes at the stalk of the
bud must fuse causing separation of the virus particle (bud)
from the host cell and release of virions into the extracellular
environment.
These sub-viral components are: (a) the viral core or vRNP
containing vRNA, NP, NEP, and 3P proteins; (b) M1, forming
the bridge between the envelope and vRNP; and (c) the enve-
lope, containing the viral transmembrane proteins (HA, NA,
and M2) and lipids derived from host cells. Moreover, since
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cluding M1, NEP and NP play important roles in this process.
M1 provides a critical function in the nuclear-to-cytoplasmic
export of vRNP since the vRNP remains bound to nucleus in
the absence of M1 (Bui et al., 2000). It has also been shown
that NP and vRNP remain in the nucleus of cells infected
with virus particles either lacking NS vRNA or possessing
the mutant NS vRNA encoding only NS1 but not NEP pro-
tein (Neumann et al., 2000) indicating the essential role of
NEP in nuclear export of vRNP. However, NEP does not inter-
act directly with vRNPs. NEP mediates RanGTP-dependent
binding to the cellular protein Crm1 via its leucine-rich nu-
clear export signal present at the N-terminal domain. NEP
also interacts with the N-terminal domain of M1 via its C-
terminal domain. An exposed tryptophan (Trp78) surrounded
by a cluster of glutamate residues on NEP, and the basic
nuclear localization signal (NLS) of M1, is responsible for
this NEP–M1 interaction (Akarsu et al., 2003). On the other
hand, M1 binds to vRNP via its C-terminal domain (Baudin
et al., 2001). It was therefore suggested that a “daisy-chain”
complex of (Crm1–RanGTP)–NEP–M1–vRNP mediated the
export of vRNP across the nuclear envelope (Akarsu et al.,
2003). However, NP alone has also been proposed to medi-
ate vRNP export, as it interacts directly with Crm1 in vitro
(Elton et al., 2001).
Several experimental observations suggest that there are
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pnfluenza virus transcription and replication occur in the host
ell nucleus, where vRNPs are formed, the vRNPs must exit
rom the nucleus into the cytoplasm and be transported to the
ssembly site for incorporation into mature viral particles.
urthermore, influenza viruses require two additional steps
n the assembly process: (i) since the genome of influenza
irus is segmented, multiple vRNA/vRNP segments (eight
eparate segments for influenza type A and B viruses, seven
egments for influenza type C viruses) must be incorporated
nto each infectious virus particle; (ii) after bud completion,
irus particles must be released from sialic acid by NA for
ell-to-cell spread and transmission.
.1. Transport of viral components to the assembly site
Since influenza viruses assemble and bud from the plasma
embrane, complete influenza virus particles are not found
nside infected cells. Therefore, all subviral components must
e directed to the plasma membrane and, more specifically,
o the apical domain of the plasma membrane in polarized
pithelial cells (bronchial and lung epithelia of infected hosts
nd MDCK cells in culture).
.1.1. Exit of vRNP from the nucleus of infected cells
Since vRNPs are synthesized in the nucleus, they must
e exported from the nucleus into the cytoplasm and to the
ssembly site on the plasma membrane for envelopment and
udding. Current reports give evidence that the vRNPs are
xported from nucleus into cytoplasm via the cellular Crm1-
ediated nuclear export pathway (Elton et al., 2001; Ma et
l., 2001; Watanabe et al., 2001a) and three viral proteins in-ikely to be two classes of vRNPs in the host cell nucleus
for review, see Nayak and Hui, 2002). One class of vRNP
s involved in active transcription and replication and is not
ikely to be exported out of the nucleus. On the other hand,
nother class of vRNPs remains transcriptionally inactive,
equestered from the transcriptionally active vRNPs and is
xported out of the nucleus for eventual incorporation into
rogeny virions. It was observed that in released progeny
irus particles, polymerase molecules were present only at
ne end of the vRNP (Murti et al., 1988) but not all over
he vRNP as would be expected if the progeny vRNPs were
ndergoing active transcription during their exit from the nu-
leus. Furthermore, dependence of in vitro mRNA synthesis
n the presence of 5′ primer and the incorporation of 5′ primer
nto mRNA using vRNP template would also support genuine
ranscription initiation (Rao et al., 2003). On the other hand,
simple chain elongation, independent of primer require-
ent, would occur if the vRNPs were exported out of the
ucleus in a transcriptionally active form and were incorpo-
ated into progeny virus particles. However, how the progeny
RNPs are rendered transcriptionally inactive in the nucleus
emains unclear. Since M1 can bind to vRNA (Baudin et al.,
001; Ye et al., 1999) and inhibit transcription (Hankins et
l., 1990), it is possible that a few M1 molecules can bind at
he critical site on either the progeny vRNA or the viral poly-
erase complex and render those vRNPs transcriptionally
nactive (for review, see Nayak and Hui, 2002). This hypoth-
sis favors the model of ‘daisy-chain’ complex of (Crm1 and
anGTP)–NEP–M1–vRNP (Akarsu et al., 2003) instead of
irect interaction of Crm1 and NP mediating the nuclear ex-
ort of vRNPs.
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2.1.2. Transport of viral envelope proteins to the apical
cell surface
Among the viral components, most information is avail-
able about the transport, sorting and targeting of viral enve-
lope proteins (HA, NA, and M2) to the virus assembly site.
In virus-infected cells as well as in cells expressing envelope
proteins individually from cloned cDNAs, each viral enve-
lope protein (HA, NA, and M2) preferentially accumulates
at the virus assembly site, i.e. the apical plasma membrane
in polarized epithelial cells (Hughey et al., 1992; Jones et al.,
1985; Roth et al., 1983). These and other studies showed that
HA, NA, and M2 possess the determinants for sorting and
targeting to the apical plasma membrane in polarized epithe-
lial cells. Although the apical sorting signal of M2 is yet to be
defined, the apical sorting signals for HA and NA have been
studied in detail. Both HA and NA possess two apical deter-
minants: one in the ectodomain, which is likely to be glycan,
and other in the transmembrane domain (TMD). Unlike the
basolateral signals, the cytoplasmic tail (CT) of either HA or
NA does not contain the apical signal. Moreover, both HA
and NA have been shown to interact with non-ionic detergent-
resistant lipid microdomains (lipid rafts) and the determi-
nant(s) for raft-association resides in their TMDs (Kundu et
al., 1996; Lin et al., 1998). Furthermore, it has been shown
that both apical (e.g. influenza HA and NA) and basolateral
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sorted randomly whereas an HA mutant transported predom-
inantly to the apical plasma membrane without significant
raft-association (Lin et al., 1998). Moreover, deletion of the
CT of HA caused a reduction in raft-association (Zhang et
al., 2000) without affecting its apical transport. These results
again support that the determinants for apical transport and
raft-association were not identical although raft-association
facilitated apical sorting and both resided in the TMD of HA
and NA.
2.1.3. Transport of M1 and vRNP to the assembly site
M1, the most abundant viral protein in the virus particle,
plays a critical role in the processes of virion assembly and
budding. For assembly and budding, both M1 and the vRNP
must be transported to the assembly site. However, how M1
and the vRNP individually or jointly are transported to the
budding site remains unclear. Nuclear translocation of M1 in
virus-infected cells unlike that observed in cDNA-transfected
cells, does not depend on the function of the M1 NLS, since
a mutant M1 protein lacking an NLS can enter the nucleus
when expressed with other viral components, particularly NP
and vRNA (Huang et al., 2001; Perez and Donis, 1998). Nei-
ther HA nor NA is absolutely required for virus budding, since
virus particles lacking either HA or NA can bud in HA or NA
temperature sensitive (ts) mutants at the restrictive tempera-
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me.g. vesicular stomatitis virus [VSV] G) proteins are synthe-
ized in the same compartment of membrane-bound polyri-
osomes and are transported together from the ER through
he cis-,mid- to trans-Golgi network (TGN). However, trans-
ort of the apical and basolateral proteins from the TGN to
he respective plasma membrane domains occurs via separate
ransport vesicles (Wandinger-Ness et al., 1990).
The role of the TMD in apical sorting and lipid raft as-
ociation were first demonstrated with NA, a type II trans-
embrane protein (Kundu et al., 1996). Further analysis of
he TMD showed that signal(s) for apical transport in the
MD of NA were not present in a specific peptide sequence
ut extended over multiple regions of the TMD and that 19
mino acids (aa 9–27) of the NA TMD were sufficient for
pical transport (Barman and Nayak, 2000). Moreover, it was
lso shown that the exoplasmic half of NA TMD amino acid
equences was critical for lipid raft association. However, al-
hough the determinants for both apical transport and lipid
aft association resided in the NA TMD and overlapped each
ther, they were not identical (Barman and Nayak, 2000). Fur-
hermore, deletion of the CT of NA caused a reduction in raft-
ssociation (Zhang et al., 2000), though the CT-minus NA
rotein was transported predominantly to the apical plasma
embrane in polarized epithelial cells.
Mutational analysis of the amino acids in the HA TMD
howed that amino acid sequences in the middle of TMD
ere most important for apical sorting and that the exoplas-
ic half of the TMD amino acid sequences were critical for
ipid raft association. However, as for NA, raft-association
id not completely correlate with apical transport of HA.
ome mutants exhibiting high degree of raft-association wereure (Palese et al., 1974; Pattnaik et al., 1986). Besides, virus
udding has been shown to occur in the absence of NA (Liu
t al., 1995). On the other hand, virus budding does not oc-
ur in the absence of M1, and M1 expressed alone can form
irus-like particles in transfected cells (Go´mez-Puertas et al.,
000; Latham and Galarza, 2001). In virus-infected polarized
ells, as expected, both M1 and NP are observed at the apical
lasma membrane (Mora et al., 2002). M1 and NP proteins
re synthesized by the nonmembrane-bound polyribosomes
nd do not use the exocytic pathway for transport. Further-
ore, M1 and NP proteins expressed individually or together
re not transported to the apical plasma membrane (Barman
nd Nayak, unpublished data). Also, M1 and NP, when co-
xpressed, do not interact with each other in the absence of
RNP (Huang et al., 2001; Zhao et al., 1998). Therefore, the
ossibility exists that the M1 and M1–vRNP complex may
e directed to the assembly site by a piggy-back interaction
uring exocytic transport of HA and NA (Ali et al., 2000).
urthermore, cytoskeletal components, particularly microfil-
ments, interact with the NP, vRNA of the vRNP and the
1–vRNP complex and thereby may facilitate the transport
f these components to the assembly site (Avalos et al., 1997).
.2. Interaction among the viral components
.2.1. Interaction of M1 with vRNP and M1 with M1
Virus assembly and budding require that three subviral
omponents, namely the viral envelope, M1 and vRNP, must
nteract with each other. Virion structure implies that M1 acts
s a bridge between the envelope and the vRNP and therefore
ust interact with both the viral envelope on the outer side
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and the vRNP on the inner side. As stated earlier, M1 was
shown to interact with viral NEP (Akarsu et al., 2003; Ward
et al., 1995; Yasuda et al., 1993), and vRNPs (Watanabe et
al., 1996; Ye et al., 1999; Zvonarjev and Ghendon, 1980).
The M1–vRNP complex can be isolated from either infected
cells or purified virions by non-ionic detergent treatment un-
der conditions where membrane glycoproteins are dissoci-
ated. M1–vRNP complexes are stable at neutral pH and low
salt and can be dissociated only by high salt and acidic pH
treatment (Zhirnov, 1992). However, the nature of M1–vRNP
interaction is unclear at present since, as mentioned earlier,
M1 does not interact with NP when expressed from cloned
cDNAs (Zhao et al., 1998). It is likely that the M1–vRNP
complex is formed by the interaction of M1 with the RNA
of the vRNP. It has been shown that M1 interacts with the
vRNP and inhibits transcription (Watanabe et al., 1996; Ye
et al., 1987, 1999). Furthermore, M1 has been shown to bind
ssRNA in vitro (Elster et al., 1997) and to vRNP in virus-
infected cells (Lopez-Turiso et al., 1990; Ruigrok and Baudin,
1995) and in virus particles (Schulze, 1972), but M1 does not
bind to NP expressed alone (Huang et al., 2001; Zhao et al.,
1998). Also, the vRNA in the helical vRNP complex of in-
fluenza virus is exposed outside of the NP and is therefore
available for interaction with M1. It was therefore postulated
that M1 binds to the vRNP via negative charges on the ex-
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proteins and vRNP and that M1 interacts with the envelope
proteins, namely HA, NA, and M2, on the outer side. How-
ever, experiments to demonstrate direct interaction of HA and
NA with M1 yielded contradictory results. Since a significant
fraction of M1 alone was shown to bind membrane (Bucher
et al., 1980; Gregoriades and Frangione, 1981; Hay, 1974;
Ruigrok et al., 2000), coexpression of M1 with HA and NA
did not significantly increase the membrane association of
M1 (Kretzschmar et al., 1996; Zhang and Lamb, 1996). How-
ever, in one report, the HA and NA CTs have been shown to
stimulate the membrane association of the M1 protein (Enami
and Enami, 1996), and short synthetic peptides of the HA cy-
toplasmic sequence inhibited virus production (Collier et al.,
1991). Subsequently, Triton X-100 (TX-100) detergent treat-
ment at low temperature was used to demonstrate the specific
interaction of M1 with both HA and NA (Ali et al., 2000).
Both HA and NA were shown to associate with lipid rafts
and become TX-100 resistant but M1 expressed alone was
not raft-associated and was TX-100 soluble. However, when
M1 was coexpressed with HA and NA, the membrane-bound
M1 interacting with mature HA and NA became resistant to
TX-100 either due to direct or indirect association of M1 with
lipid rafts. Moreover, the interaction of M1 with HA and NA
was shown to be specific for TX-100 resistance of M1 since
the membrane-bound M1 in cells coexpressing M1 with a
h
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tosed RNA in the vRNP (Baudin et al., 1994). Clusters of
ositive charges on the helix 6 (H6) domain (aa 91–105) are
elieved to interact with negative charges (PO4−) of RNA.
owever, this view has been questioned by a number of work-
rs since the C-terminal fragment (aa 165–254) of M1, which
oes not bind to RNA, can bind to the vRNP (Baudin et al.,
001; Ye et al., 1999) and the N-terminal fragment (aa 1–164)
hich binds RNA, does not bind the vRNP (Baudin et al.,
001; Watanabe et al., 1996). Furthermore, only the entire
1 (aa 1–252), which binds both RNA and the vRNP, causes
ranscription inhibition (Baudin et al., 2001). Interaction be-
ween the M1 protein and RNA was demonstrated by using
lter-binding assays and blotting procedures (Wakefield and
rownlee, 1989; Ye et al., 1989). However, such artificial
nteraction of M1 with single stranded RNA is non-specific.
oreover, although the M1 protein contains a putative zinc
nger motif, this motif is not involved in any biological func-
ion in virus replication in cultured cells (Hui et al., 2003b).
M1 interacts with itself and forms dimers and multimers
Zhao et al., 1998) and this interaction is expected to involve
equences in the M domain (Harris et al., 2001). M1–M1
nteraction is critical in many aspects of virus budding, in-
luding concentration of viral components at the budding
ite, exclusion of host proteins from virions, formation of the
symmetry in lipid membrane at the budding site, initiation
f membrane bending and bringing host components to the
udding site for closure of virus buds.
.2.2. Interaction of M1 with envelope proteins
As mentioned earlier, the position of M1 in the viral struc-
ure implies that M1 forms a bridge between the envelopeeterologous protein such as Sendai virus F protein, was not
X-100 resistant (Ali et al., 2000).
Furthermore, chimeras between HA and Sendai virus F
roteins showed that both CT and the TMD of HA rendered
he membrane-bound M1 resistant to TX-100, supporting
he interaction M1 with both CT and TMD of HA. Analysis
y confocal microscopy also demonstrated that in influenza
irus-infected cells, a fraction of M1 was colocalized with
A both in the presence and absence of monensin (Ali et al.,
000). In the presence of monensin, an inhibitor of exocytic
ransport, HA was present predominantly in the perinuclear
olgi region and was absent from the plasma membrane. M1
as also more concentrated in the perinuclear region and less
n the cell periphery, supporting colocalization of M1 and HA
n the Golgi region of influenza virus-infected cells (Ali et
l., 2000). Fractions of M1 and NP also colocalized in virus-
nfected cells (Avalos et al., 1997). These biochemical and
orphological analyses demonstrated the interaction of M1
ith lipid membranes, HA, NA, and the vRNP in influenza
irus-infected cells.
. Selection of the budding site
It is generally believed that viral glycoproteins determine
he site of virus assembly and budding. This notion comes
rom the fact that viral glycoproteins accumulate at the site
f virus budding even when expressed alone. For example,
lycoproteins of viruses such as hepatitis B virus, bun-
aviruses, coronaviruses, and others that bud from the in-
ernal sub-cellular organelles, possess intrinsic determinants
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for the same sub-cellular localization as the site of virus bud-
ding (for review, see Hobman, 1993). On the other hand, for
viruses budding from the plasma membrane, the viral glyco-
proteins possess either apical or basolateral sorting signals
and are directed to the specific site where virus assembly and
budding occur in polarized epithelial cells. Furthermore, in
different cells and tissues where some viruses bud from the
opposite domains of the plasma membrane, their glycopro-
teins are distributed accordingly. For example, Semliki Forest
viruses (SFV) buds apically from FRT cells but basolaterally
from CaCo-2 cells; similarly, in the absence of any other viral
protein, p62/E2, the envelope glycoproteins of SFV, are tar-
geted apically in FRT cells but basolaterally in CaCo-2 cells
(Zurzolo et al., 1992). For retroviruses, particularly the hu-
man immunodeficiency virus (HIV) that buds from the baso-
lateral surface in polarized epithelial cells, the HIV envelope
protein is also directed basolaterally. HIV capsid proteins ex-
pressed alone released virus-like particles (VLPs) randomly
from both apical and basolateral surfaces, whereas upon ex-
pression of the envelope protein gp160, particles were re-
leased predominantly from the basolateral surface (Owens
et al., 1991). The authors concluded from these studies that
the HIV envelope protein, which is targeted to the basolat-
eral surface in polarized epithelial cells, determines the site
of virus budding.
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other viral components including M1 and vRNP as well as
host components may be involved in determining the budding
site.
4. Bud formation and completion
Budding requires the selection of an assembly site where
viral components are transported and assembled leading to
the initiation of the budding process, growth of the bud and
finally, completion of the bud with the release of the virus
particles. Each of the steps in the budding process is complex
and requires involvement of both host and viral components.
Influenza viruses not only bud from the plasma membrane,
but they bud from the apical domain of the plasma membrane
in polarized cells. In addition, influenza viruses do not bud
randomly from the plasma membrane but discretely from pre-
ferred sites in the membrane. Alternatively, as proposed for
murine leukemia virus (MuLV), budding of one virion may
seed for the next in the same site and a defect in bud release
could lead to joining of multiple particles forming filaments
and this process may be coupled with the recruitment of host
cytoskeletal elements at the preferred site of budding (Yuan
et al., 2000). With influenza virus, cytoskeletal-disrupting
agents caused an increased release of spherical over fila-
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iInfluenza virus, which assembles and buds from the api-
al plasma membrane in polarized epithelial cells, has been
sed extensively as a model for studying protein targeting.
f the three transmembrane envelope proteins, HA is the
ajor glycoprotein, comprising over 80% of the envelope
roteins present in the virus particle. In transfected cells, a
ingle amino acid change (Cys543→Tyr543) in HA (HAtyr)
as shown to direct HAtyr predominantly to the basolateral
ide without significantly affecting the intracellular transport
nd cell surface expression of the mutant protein (Brewer
nd Roth, 1991). Recently, using transfectant influenza virus
ontaining basolaterally targeted HA (Cys543→ Tyr543), it
as shown that the basolateral targeting of HA did not sig-
ificantly alter the apical budding of influenza virus (Barman
t al., 2003; Mora et al., 2002). Over 99% of the virus par-
icles containing the HAtyr were released from the apical
ide even though the majority of HAtyr was directed to the
asolateral side. However, the role of NA and M2 in polar-
zed budding of influenza virus has not been examined yet.
imilarly, when a mutant vesicular stomatitis virus (VSV) G
rotein was targeted apically, it did not affect the basolateral
udding of VSV (Zimmer et al., 2002). It was also demon-
trated that although measles virus glycoproteins H and F
ere transported in a random fashion or to basolateral mem-
rane, respectively, virus budding occurred predominantly
rom the apical surface of polarized MDCK cells (Maisner
t al., 1998). Similarly, although Marburg virus buds pre-
ominantly from the basolateral surface, its glycoprotein was
ransported to the apical surface (Sanger et al., 2001). These
tudies suggest that viral glycoproteins may not be the only or
ajor determinant for selecting the site of virus budding andentous particles in MDCK cells (Roberts and Compans,
998) and release of virus particles in a few localized regions
f the plasma membrane in abortively infected HeLa cells
Gujuluva et al., 1994).
Bud formation and bud release are the last steps in viral
eplication and production of new infectious virions. Initi-
tion of bud formation requires bending of membrane and
nvolves a transition from more planar membrane structure
o a curved structure (for review, see Farsad and De Camilli,
003; Lippincott-Schwartz and Liu, 2003). Recently, a newly
ecognized BAR (Bin/Amphiphysin/Rsv) domain has been
emonstrated to be involved in membrane curvature (Peter
t al., 2004). This domain is present in a number of proteins
nvolved in vesicle formation and recycling, such as am-
hiphysins, endophilins, arfaptins, nadrins, beta-centauins,
nd oligophrenins (for review, see Habemann, 2004; Lee and
chekman, 2004; Zimmebeg and McLaughlin, 2004). How-
ver, the role of any of these proteins in virus budding is
nknown. Both lipids and proteins are likely to contribute
o causing membrane curvature. Asymmetry in lipid bilayers
an cause intrinsic curvature of one monolayer relative to the
ther monolayer leading to membrane bending (Holopainen
t al., 2000). Therefore, assembly of lipid bilayers into spe-
ific lipid microdomains such as lipid rafts at the site of
udding is likely to contribute to virus budding. In addition
o specific lipid microdomains, virus bud formation requires
pecific viral proteins.
Two types of proteins that are associated with the viral en-
elope, namely (i) the transmembrane proteins HA, NA and
2 forming the outer spikes and (ii) the matrix protein M1
nteracting with the inner leaflet of the lipid bilayer, appear to
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play a critical role in budding. Clustering of M1 on the inner
bilayer can cause membrane bending and initiation of bud-
ding. Finally, pinching off of the virus buds requires fusion of
the apposing viral and cellular membranes leading to fission
and separation of the bud from the cell (for review, see Nayak
and Hui, 2004). Furthermore, influenza virus particles are
pleomorphic. Although laboratory-adapted viruses are usu-
ally spherical, viruses freshly isolated from the field are gen-
erally filamentous. However, some laboratory-adapted strains
(e.g. A/Udorn/72 [H3N2]) are also filamentous (Bourmakina
and Garcia-Sastre, 2003; Roberts et al., 1998). Factors af-
fecting the fusion of the lipid bilayers and fission of the bud
will affect the size and shape of the virus particles. Among
the viral components, M1 proteins have been shown to be the
key component in both bud formation and pinching off (for
review, see Nayak and Hui, 2002, 2004). In addition to viral
components, a number of host components play a critical role
in bud completion and virus release (for review, see Freed,
2002, 2003; Luban, 2001; Pornillos et al., 2002).
5. Role of M1 in virus budding
M1 is the most abundant protein in the influenza virion
and plays critical roles in many aspects of the virus life cycle
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sembling viral and host components required for budding at
the assembly site of the plasma membrane (for review, see
Lamb and Krug, 2001; Nayak, 2000; Nayak and Hui, 2002).
M1–M1 interaction facilitates the formation of an M1 protein
patch and the exclusion of host proteins from the assembly
and budding site. M1 was shown to be a determinant for
morphological shape and size (filamentous versus spherical)
of influenza particles (Bourmakina and Garcia-Sastre, 2003;
Hughey et al., 1995; Liu et al., 2002; Roberts et al., 1998).
Since the M1 protein alone in the absence of any other vi-
ral proteins becomes membrane-associated (Ali et al., 2000;
Kretzschmar et al., 1996) and produces VLPs in the extra-
cellular medium (Go´mez-Puertas et al., 2000; Latham and
Galarza, 2001), the M1 protein has all the structural infor-
mation needed for self-assembly, interaction with the plasma
membrane, as well as initiation, completion and release of
the bud. However, the interaction of M1 with both viral in-
tegral membrane proteins and newly assembled vRNP in the
plasma membrane is believed to increase the efficiency of
viral budding.
The matrix proteins of many negative strand viruses and
the Gag proteins of retroviruses possess specific motifs called
late (L) domains which are involved in recruiting the host
components required for bud completion and virus release
(for review, see Cimarelli and Darlix, 2002; Freed, 2002,
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including virus budding (for review, see Nayak, 1996; Nayak
nd Hui, 2002). These include: (i) M1 interaction with vRNP
nd NEP and regulation of vRNP transport between the cy-
oplasm and the nucleus (for review, see Cros and Palese,
003; Portela and Digard, 2002); (ii) regulation of vRNP
ranscription and replication; (iii) interaction with viral en-
elope proteins (HA, NA, and M2); (iv) recruitment of viral
omponents at the assembly site and initiation of budding;
v) recruitment of host components for bud completion and
irus release.
The M1 monomer is 60 A˚ long and possesses two globular
egions (aa 1–164 and 165–252) linked by a protease sensi-
ive loop. The structure consists mostly of helix and loops and
s devoid of-strands (Shishkov et al., 1999). The N-terminal
ragment (aa 1–164) has been crystallized at both acidic and
eutral pH and the 3-D structure has been determined by X-
ay diffraction analysis (Arzt et al., 2001; Harris et al., 2001,
999; Sha and Luo, 1997). This fragment contains eight loops
L) and nine helices (H) but the last loop (aa 159–164) was
ot resolved in the X-ray diffraction study. The H6 domain
aa 91–105) of M1 provides multiple functional domains in-
luding a nuclear localization signal, an RNA-RNP binding
ite, transcription inhibition motifs, and others.
M1 is the major driving force of influenza virus budding,
ince in the absence of M1 VLPs are not formed (Go´mez-
uertas et al., 2000; Latham and Galarza, 2001). M1 aids in
he assembly and budding process in multiple ways. M1 in-
eracts with the inner leaflet of the lipid bilayer and thereby
reates asymmetry in the membrane bilayer causing outward
ending for the initiation of bud formation. M1 is believed
o be the key protein in recruiting, concentrating, and as-003; Luban, 2001; Perez and Nolan, 2001; Pornillos et al.,
002; Yap and Stoye, 2003). So far, three different L domain
otifs, namely PP(P/X)Y (PY motif or proline-rich motif),
(T/S)AP, and YP(D/X)L motifs have been found in the ma-
rix proteins of negative strand viruses as well as retroviruses
ncluding HIV. These motifs have been shown to interact with
number of cellular proteins involved in bud completion (for
eview, see Freed, 2002, 2003; Luban, 2001; Perez and Nolan,
001; Pornillos et al., 2002; Yap and Stoye, 2003). Recent
tudies using site-directed mutagenesis and rescuing mutated
iruses by reverse genetics have shown that the helix 6 (H6)
omain of influenza A virus M1 also possesses a L domain-
ike motif (Hui et al., 2003a). Mutation in H6 (R101A) was
hown to reduce virus yield due to a budding defect produc-
ng filamentous particles (Fig. 1). The morphological phe-
otype of the R101A M1 mutant was strikingly similar to
hat observed for MuLV Gag mutants with L domain defects
Yuan et al., 2000). Both the R101A influenza virus mutant
nd the MuLV mutant exhibited elongated filamentous mor-
hology. Many filaments contain multiple spherical units, a
daisy chain like structure” (Fig. 2B), suggesting a defect
n releasing spherical particles during budding as was also
een with MuLV (Yuan et al., 2000) and other retrovirus L
otif mutants (Garrus et al., 2001). Furthermore, the YRKL
equence of influenza M1 H6 domain can be replaced by a
oreign L motif such as PTAP or YPDL but not by PPPY.
nsertion of the YRKL into different locations of the mu-
ated M1 protein restored normal budding but not the NLS
unction (Hui and Nayak, unpublished data). These results
howed the interchangeable nature of the L domain motif of
nfluenza virus M1. Taken together, these data indicate that
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Fig. 1. Mutations in M1 and NA produce elongated influenza virus particles in MDCK cells. MDCK cells grown on polycarbonate filters were infected with
different viruses at 3.0 MOI. At 12 h p.i., infected cell monolayers were examined by thin section electron microscopy. Results show that cells infected with
an M1 mutant (R101A, panel B), and NA CT mutant (NA3A2, panel D) and NA TMD chimeras with TR [NATRNA and NA(1T2N)NA, panels C and E,
respectively], produced elongated particles (→), whereas cells infected with WT virus produced mostly spherical particles (panel A). This figure was adapted
from (Hui et al., 2003a) and (Barman et al., 2004) with the permission of American Society for Microbiology.
YRKL sequence and the neighboring region function as the
L domain in influenza virus budding. Although the precise
sequence and boundary of the L domain motif of influenza
virus M1 are yet to be determined, the influenza L domain
consists at least partly of the positively charged residues of
the NLS sequence. Furthermore, since the Y and L of YRKL
sequence can be replaced (Hui et al., 2003a), it does not rep-
resent a known L motif.
Like other viral L domains, the influenza virus L domain
appears to function in bud completion rather than bud initia-
tion and may be involved in recruiting host proteins required
for bud completion and release of virus particles. In other
viruses, the domains (P[T/S]AP, PP[P/X]Y, and YP[D/X]L)
have been shown to interact with a number of host pro-
teins involved in endocytic vacuolar sorting pathways such
as Tsg101, Nedd4, ubiquitin ligases, AP2, and proteins con-
taining SH3 and WW domains (for review, see Freed, 2002,
2003; Luban, 2001; Perez and Nolan, 2001; Pornillos et al.,
2002; Yap and Stoye, 2003). However, host protein(s) in-
teracting with the influenza virus L-like motif involved in
budding have not yet been identified. It is likely that posi-
tively charged residues of the H6 domain may interact with
a different set of host proteins which may be involved in api-
cal budding whereas the PTAP and YPDL sequences may
interact with proteins involved in basolateral budding.
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2001b). HA is the most abundant envelope protein (∼80%).
However, HA may also have little role in the process of
virus budding and release. Viruses lacking HA have been
shown to release virus particles efficiently into the extra-
cellular medium (Go´mez-Puertas et al., 2000; Latham and
Galarza, 2001; Pattnaik et al., 1986), although such particles
are not infectious. HA lacking the CT did not cause aberrant
virus budding or virus morphology (Jin et al., 1997).
On the other hand, several studies suggest that NA plays
a critical role in virus budding (Jin et al., 1997). Although
NA is not an absolute requirement for influenza viral mor-
phogenesis (Garcı´a-Sastre and Palese, 1995; Mitnaul et al.,
1996), NA is clearly an important player in optimal virus
replication. In cells infected with a mutant virus lacking NA,
progeny viruses were not only aggregated on the cell-surface,
but most of the virus particles exhibited an elongated mor-
phology indicating a possible defect in the budding process
(Liu et al., 1995). Moreover, elongated morphology of mu-
tant virus particles suggests that the defect is in bud release
rather than bud formation. Six amino acids of the NA CT are
extremely conserved and are likely to play an important role
in virus budding. Studies using tail minus HA (HAt−) and
NA (NAt−) mutant viruses showed that NAt− (Mitnaul et
al., 1996) but not HAt− (Jin et al., 1994) virus particles were
elongated in shape. In addition, deletion of the CTs of both
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w.1. Role of transmembrane proteins in virus budding
Among the three transmembrane viral envelope pro-
eins (HA, NA, and M2), M2 is only a minor component
16–20 molecules/virion) and is therefore unlikely to play a
ignificant role in budding. Moreover, recently it has been
hown that the presence of M2 is not an obligatory require-
ent for virus replication. Infectious virus lacking M2 can
e rescued and propagated in cell culture (Watanabe et al.,A and NA led to formation of bizarre filamentous virus par-
icles (Jin et al., 1997). The authors further observed that CT
eletion caused a reduction in raft association and concluded
hat reduced raft association was responsible for the budding
efects (Zhang et al., 2000). However, complete deletion of
he CT of NA could cause structural perturbation leading to
rotein instability and reduced lipid raft association. Recent
tudies using mutational analysis of the transmembrane and
ytoplasmic domains of NA have shown that some TMD as
ell as CT residues play critical roles in viral morphogenesis
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including virus shape, size, and titer (Barman et al., 2004).
When the extreme N-terminal three amino acids of NA were
replaced with alanine, the mutant virus particles exhibited
elongated shape (Fig. 1) although its lipid raft-association
was normal. Similarly, NA/TR chimeras containing complete
or partial replacement of the NA TMD with human transferrin
receptor (TR) TMD also caused a budding defect producing
elongated particles (Fig. 1). Therefore, it is likely that NA
either directly or indirectly may have a role in the budding
process independent of raft-association (Barman et al., 2004)
(Fig. 1).
5.2. Role of the eight vRNP segments in virus budding
Although vRNP segments are not absolutely required for
budding since M1 proteins alone can initiate and release
virus buds (Go´mez-Puertas et al., 2000; Latham and Galarza,
2001), incorporation of all eight (influenza A and B) or seven
(influenza C) vRNA segments is required for the formation
of infectious virus particles. However, how these multiple
vRNA segments are incorporated into virus particles remains
unclear. Two models have been proposed for the incorpora-
tion of eight vRNA segments into virions; i.e. “random pack-
aging” and “specific packaging”. The “random packaging”
model predicts the presence of common structural elements
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is as yet not evidence in support of specific vRNP segment
requirement for bud formation and bud closure since M1 pro-
tein alone can form buds and release VLPs (Go´mez-Puertas
et al., 2000; Latham and Galarza, 2001).
5.3. Role of lipid rafts in virus budding
Viral morphogenesis is a complex phenomenon requiring
concerted actions of many viral and host components (for
review, see Cadd et al., 1997; Garoff et al., 1998; Nayak,
2000; Pettersson, 1991; Simons and Garoff, 1980). Among
the host components that are intimately involved in regulating
different aspects of the influenza virus life cycle, lipid rafts
play a number of important roles. Lipid rafts are lipid mi-
crodomains enriched in sphingolipids and cholesterol. They
contain lipids in liquid order (lo) and are relatively resistant
to non-ionic detergent at a low temperature (for review, see
Brown and London, 1998; Simons and Toomre, 2000). Lipid
rafts play critical roles in many aspects of the virus life cy-
cle such as virus entry and uncoating, viral protein transport
and targeting, selection of the viral assembly site, interac-
tion among viral components, and finally, the budding pro-
cess including bud initiation and bud completion (for review,
see Barman et al., 2001; Chazal and Gerlier, 2003; Kielian
et al., 2000; Nayak and Barman, 2002; Nayak and Hui,
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tn all vRNPs causing them to be incorporated randomly into
irions. Support for this model comes from the observation
hat influenza A virions can possess more than eight vRNPs
9–11 vRNAs per virion) (Bancroft and Parslow, 2002; Enami
t al., 1991). On the other hand, the “specific packaging”
odel assumes specific structural features in each vRNA
egment, enabling them to be selectively incorporated into
irions. Evidence for this model is deduced mainly from the
nding that the various vRNAs are equimolar within viral
articles even though their concentrations in infected cells
ay differ (Smith and Hay, 1982). Earlier studies demon-
trating that the DI vRNAs can competitively inhibit the
ackaging of their normal counterparts but not that of other
RNAs argue for the specific packaging model (Duhaut and
cCauley, 1996; Nakajima et al., 1979; Nayak et al., 1982,
989; Odagiri and Tobita, 1990). Moreover, recent studies
ave shown that in addition to 5′ and 3′ non-coding se-
uences, specific coding sequences are required for efficient
ackaging of HA (Watanabe et al., 2003), NA (Fuji et al.,
003), M and NS genes (mentioned in Watanabe et al., 2003).
xistence of specific packaging sequences would argue in
avor of specific packaging over random incorporation of
RNA segments. Specific vRNA–vRNA interaction among
he vRNP segments in trans would be involved in forming
ulti-segmental vRNA macromolecules for incorporation in
irus particles. However, such a model would require that
uch large vRNP complexes containing eight unique vRNPs
roduced by RNA–RNA interactions in vRNPs in trans are
table. More importantly, bud closure and virus release will
ot occur until such vRNP complexes containing eight spe-
ific vRNP segments are formed. As mentioned earlier, there004).
Among the three influenza viral envelope proteins, both
A (type I) and NA (type II) proteins use lipid rafts as a plat-
orm for apical transport (for review, see Nayak and Barman,
002; Nayak and Hui, 2004) but M2, although an integral
embrane protein, does not use lipid rafts for apical transport
Zhang et al., 2000). Furthermore, in the envelope of released
irions, both HA and NA remain raft-associated but M2 does
ot associate with the lipid rafts, indicating that the influenza
iral envelope also exhibits a mosaic mixture of both raft
nd non-raft lipid microdomains even though the majority of
ipids present in the lipid bilayer of the viral envelope are in
he lo phase. Association of HA with lipid rafts is not de-
endent on oligosaccharide modification or its association
ith other viral proteins or its assembly into virus particles.
either does the association of HA with lipid rafts depend
n the polarity of cells (Skibbens et al., 1989). The TMD of
A has critical determinants for interacting with lipid rafts
ince chimeric proteins containing the TMD of VSV G or
SV C proteins and the ectodomain and CT of HA did not
ssociate with lipid rafts. Furthermore, the exoplasmic half
f the HA TMD was critical for lipid raft-association (Lin
t al., 1998; Scheiffele et al., 1997, 1999). In addition, palmi-
oylation of three cysteine residues present in the HA TMD
nd CT as well as structural features such as the -helical
onformation of the HA TMD peptide aid its interaction with
ipid rafts (Melkonian et al., 1999; Tatulian and Tamm, 2000).
ail-minus HA (HAt−) exhibited markedly reduced TX-100
esistance both in released virus particles and in cDNA trans-
ected cells (Zhang et al., 2000). This could be partly due to
he loss of two cysteine residues in the CT.
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NA, a type II integral influenza virus protein, also asso-
ciates with lipid rafts via its TMD during intracellular trans-
port (Barman et al., 2001; Barman and Nayak, 2000). How-
ever, unlike HA, interaction of the NA TMD with lipid rafts
was not dependent on acylation of cysteine residues. Like HA,
the CT of NA affected the interaction of NA in the lipid raft
since removal of the conserved CT reduced raft-association
and increased TX-100 solubility of NA (Zhang et al., 2000).
Lipid rafts also play an important role in pseudotyping.
Pseudotyping is a common phenomenon observed in cells co-
infected with two or more enveloped viruses where progeny
viruses containing the genome (and capsid) of one virus and
the envelope proteins of a second virus are formed. This type
of mixing of core (capsid) components with envelope compo-
nents has been observed with many DNA and RNA viruses
(Pickl et al., 2001). This well-documented phenomenon of
pseudotyping is at odds with the common notion that spe-
cific interaction between the core component and envelope
proteins governs the assembly and budding of most viruses.
It appears that lipid rafts facilitate pseudotyping by forming
a common platform for mixing the envelope proteins of dif-
ferent viruses and cellular membrane proteins. Even viruses
belonging to diverse groups such as herpes simplex virus and
VSV can produce pseudotyped viruses. A common property
among all these diverse viral and cellular proteins are that
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lope. Lipid rafts therefore provide the basis for promiscuity in
the incorporation of foreign proteins into a number of virus
particles such as VSV, HIV, and influenza virus and sup-
port the passive incorporation of integral membrane proteins
into virus particles. However, envelope protein and core in-
teractions also play a critical role in selecting incorporation
of specific viral proteins and in excluding most membrane-
associated host proteins from the budding site and from virus
particles. Therefore, lipid microdomains such as lipid rafts fa-
cilitate mixing and interaction among the viral components
required for assembly and budding of infectious viruses as
well as in pseudotype formation.
Lipid rafts, in addition to transporting, targeting and con-
centrating viral and host components to the assembly site,
may have some intrinsic properties for initiating budding and
thereby facilitate budding from specific sites of the mem-
brane for a given virus. Raft association of HA appears to be
responsible for clustering of HA on the plasma membrane
and efficient budding but has no effect on virus morphology
(Takeda et al., 2003). There are a number of reasons why dif-
ferent viruses choose different lipid microdomains for bud-
ding. Influenza virus HA and NA associate with lipid rafts,
and influenza viruses bud from lipid rafts. The presence of
specific peptides in a specific conformation often facilitates
association with lipid rafts and may increase the order of
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mhey are raft-associated and often myristoylated or palmi-
oylated. The basolateral VSV G protein is TX-100 soluble
ndicating that it is not raft-associated. However, by antibody-
nduced patching experiment, it was shown that VSV-G par-
ially co-patched with the raft-associated marker protein pla-
ental alkaline phosphatase (PLAP) indicating the partial raft
ssociation of VSV G (Harder et al., 1998). It was observed
hat in mixed infections the envelope proteins of different
iruses as well as some of the core proteins such as HIV Gag
re often raft-associated and non-ionic detergent insoluble
Pickl et al., 2001). Therefore, detergent-resistant lipid rafts
n the plasma membrane are the common meeting ground
or core and transmembrane envelope proteins of different
iruses. Also, these lipid rafts function as a platform for en-
elopment and budding resulting in the production of pseu-
otyped viruses. Some of the host components such as CD4,
XCR4, as well as the envelope proteins of retroviruses and
PI-anchored proteins can be incorporated in the viral enve-
ig. 2. (A) Schematic representation of influenza virus morphogenesis. For
he assembly site at the plasma membrane and interact with one another in a
re transported from the trans Golgi network to the budding site, a specific re
ransported via the same route but does not require lipid rafts. The Ml–vRNP
ut of the nucleus and are transported to the assembly site on the plasma m
ail of HA and NA. Ml binds to the cytoplasmic tail and transmembrane d
he plasma membrane bends at the assembly site containing glycoproteins a
usion of the apposing cellular and viral membranes leads to fission and pin
he extracellular medium. Lipid raft microdomains in the membrane are sho
efective and normal virus budding. Mutant viruses with defective budding
usion and fission of apposing cell and viral membranes. The presence of m
udding from the plasma membrane is not random but occurs at specific sit
re depicted, each influenza particles contain eight or more vRNP segmentsorphogenesis to occur, all the subviral components must be transported to
ly manner. Both glycoproteins (HA and NA) use the exocytic pathway and
the plasma membrane containing lipid rafts. Another glycoprotein (M2), is
ex, consisting of the viral genomic RNA, NP, NEP, 3P and Ml, are exported
e either via cytoskeleton elements or by piggy-backing on the cytoplasmic
f HA and NA on the outer side, and the vRNP on the inner side. Finally,
l–vRNP complexes, causing an outward membrane curvature. Eventually,
ff of the virus particle, releasing the enveloped progeny virus particle into
own; non-raft regions are depicted in grey. (B) Schematic representation of
e structures joining multiple particles (Hui et al., 2003a) due to incomplete
incomplete virus-like particles in elongated structures suggests that virus
ucing multiple virus particles from the same site. Although three segments
ipids in the lipid raft. For example, the helicity of the HA
MD peptide increased in lipid bilayers composed of acidic
ipids and in turn, the presence of the peptide also increased
he acyl chain order of the lipid bilayer. Ordered lipids at-
ract TMDs and TMDs in turn increase the order of the lipids
urrounding them. This process may aid in targeting HA and
A transmembrane proteins to ordered lipid rafts and orga-
izing ordered lipid rafts around them (Tatulian and Tamm,
000). However, incorporation of HA alone is not sufficient
o organize an ordered lipid environment since HA incorpo-
ated in the VSV envelope is TX-100 soluble (Scheiffele et
l., 1999). Furthermore, raft-dependent protein–protein in-
eractions may facilitate bringing proteins that are present in
ess-ordered membrane to lipid rafts by interaction with raft-
ssociated proteins. Interaction between influenza virus M1
nd HA brings M1, a non-raft-associated protein, into lipid
afts (Ali et al., 2000). Also, raft-ordered membrane domains
ay be formed de novo around transmembrane proteins on
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the plasma membrane such as the engaged immune recep-
tors (for review, see Cheng et al., 2001; Man˜es et al., 2001).
The affinity of lo domains can be increased by organization,
acylation, coupling to raft-associated molecules or by con-
formational changes (Harder et al., 1998).
Although viruses can bud and form particles (VLPs) in the
absence of glycoproteins and although the Gag protein of HIV
and the matrix proteins of many negative strand viruses can
bud and acquire envelope, the lipid composition of such VLPs
is not known. Whether these VLPs contain lipid rafts in their
envelope or whether glycoproteins are required for acquiring
lipid rafts in their envelope remains to be determined. The
lipid composition of a VLP’s envelope may indicate whether
virus budding occurs from the plasma membrane outside lipid
raft microdomains or whether budding requires the presence
of lipid raft microdomains.
Finally, involvement of lipid rafts in virus replication may
provide a novel antiviral approach. Topical application of
-cyclodextrin (-CD), a lipid raft destabilizer, shows the
promise of antiviral effect in HIV transmission (Khanna et
al., 2002), possibly by preventing virus entry or by disrupting
virus budding or virion structure.
5.4. Role of host proteins in virus budding
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infected cells as well as NP but not M1 alone in cells ex-
pressed from cloned cDNA interacted with F-actin (Avalos
et al., 1997; Bucher et al., 1989; Digard et al., 1999, 2001;
Husain and Gupta, 1997). Furthermore, actin was found in
many enveloped virus particles (for review, see Cudmore et
al., 1997; Eaton and Hyatt, 1989; Falke, 1997; Wang et al.,
1976). Also, actin and actin-binding protein ezrin-radixin-
moesin (ERM) have been found in influenza virus particles
(Sagara et al., 1995). The presence of actin-associated pro-
teins in virions suggests specific functions of the actin fila-
ment during assembly and budding.
Influenza virus budding was shown to be an active, energy-
dependent process requiring ATP hydrolysis (Hui and Nayak,
2001). Metabolic inhibitors (such as antimycin A, CCCP,
FCCP, and oligomycin) and ATP analogues (such as ATPS
and AMP-PNP) inhibited influenza virus budding (Hui and
Nayak, 2001). Energy is required for biomembrane bend-
ing and shape transition during bud formation (Sackmann,
1994). ATP may play a multifunctional role during influenza
virus budding by maintaining a lipid raft membrane struc-
ture favorable for virus budding, by providing the energy for
membrane shape transition or actin polymerization, and by
functioning as a molecule for protein kinase signaling during
virus budding.
Among the kinases, casein kinase 2 (CK2) is involved in
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pIn addition to lipids, a number of host proteins, including
icrofilaments, G proteins, and some protein kinases, have
een shown to be involved in the budding of many enveloped
iruses (for review, see Ludwig et al., 1999). In addition, the
amily of proteins of the vacuolar protein sorting pathway
ave been shown to interact with the L domains of the Gag
nd matrix proteins of a number of viruses. These include
sg101, other ESCRT components, and proteins containing
W domains (such as Nedd4 family proteins) (Garrus et
l., 2001; Martin-Serrano et al., 2004; Ono and Freed, 2004;
track et al., 2000, 2003; von Schwedler et al., 2003). How-
ver, for influenza viruses, host protein(s) that interact with
1 and specifically affect virus budding have not yet been
dentified. Furthermore, inhibitors of proteasomes involving
biquitination were found to inhibit budding of a number
f enveloped viruses (for review, see Vogt, 2000) although
he specific role of ubiquitination in virus budding remains
nclear. However, inhibitors of ubiquitination did not affect
nfluenza virus budding (Hui and Nayak, 2001). Cytoskeletal
lements, particularly microfilaments, have been proposed to
e involved in the maturation of influenza virus including bud
ormation and bud completion. In abortively influenza virus-
nfected HeLa cells, virus particles could be released us-
ng microfilament-disrupting agents (Gujuluva et al., 1994).
lso, the budding of filamentous influenza virus particles
as converted to spherical particles by inhibitors of actin
olymerization such as cytochalasin B (cytoB), cytochalasin
(cytoD), jasplakinolide, and latrunculin A (Roberts and
ompans, 1998; Simpson-Holley et al., 2002), suggesting
he role of actin microfilaments in bud formation and bud
elease. In addition, the vRNP–M1 protein complex in virus-nfluenza virus budding since a CK2 inhibitor disrupted virus
udding, and increased CK2 activity correlated with the repli-
ation cycle of influenza virus (Hui and Nayak, 2002). More-
ver, CK2 was found in influenza virus particles (Tucker et
l., 1990) suggesting its presence in the vicinity of the bud-
ing area of influenza virus and active involvement in the
udding process (for review, see Hui, 2002, in press). How-
ver, inhibitors of cAMP-dependent protein kinase (PKA),
rotein kinase C (PKC), and phosphatidylinositol 3-kinase
PI3K) did not affect influenza virus budding. Furthermore,
lthough the M1 protein is a phosphoprotein and both phos-
horylated M1 and NP have been found in virus particles
Gregoriades et al., 1984, 1990), there is no evidence for a
pecific requirement for phosphorylation of any viral protein
n the budding process.
.5. Bud completion
Subsequent to bud formation, buds are released by a mech-
nism of fusion of the apposing membranes and fission of the
ud from the cell membrane (Fig. 2B). These processes de-
ermine the size and shape of the particles. The mechanism
f bud completion is yet unclear and a number of factors both
iral and host may affect this process. For some viruses, such
s Semliki Forest virus, the icosahedral nucleocapsids deter-
ine the spherical shape of the released virus particles. Simi-
arly, the length of the helical VSV nucleocapsid is critical in
etermining the bullet shape and the length of the virus parti-
les. Defective interfering VSV particles contain smaller nu-
leocapsids, which are responsible for producing small virus
articles. Therefore, with these viruses, separation of virus
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buds from host membranes depends on the cargo nucleocap-
sid and occurs immediately after the enclosure of the nucleo-
capsid. However, many viruses such as influenza are flexible
and pleomorphic and can produce spherical or filamentous
particles. With these viruses, a number of factors may play
critical roles in causing the fusion and fission processes and
determining the size and shape of the released virus particles.
As mentioned earlier, among the viral components, matrix
proteins as well as glycoproteins have been shown to affect
virus shape and size. Deletion of the CT of both HA and NA
was shown to generate bizarre filamentous virus particles.
Reduced lipid raft-association of HAt−/NAt− virus was pro-
posed to be the cause of such abnormal virus particles sug-
gesting the role of lipid rafts in both budding and fission of
virus particles (Zhang et al., 2000). In addition, mutation in
the CT of NA was shown to generate spherical to filamen-
tous form not dependent on lipid raft association (Barman
et al., 2004). With some influenza virus strains (A/Udorn/72)
that exhibited filamentous morphology, M1 contributed to the
strain-specific filamentous shape (Bourmakina and Garcia-
Sastre, 2003; Roberts and Compans, 1998). Also, as men-
tioned earlier, influenza virus M1 possesses L domain activity
that affects fission of virus buds (Hui et al., 2003a).
In addition to viral factors, a number of host proteins as
indicated earlier (Section 5.4) including ubiquitin, Tsg101,
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cles from influenza virus-infected HeLa cells with actin dis-
rupting agents (Gujuluva et al., 1994), as well as increase in
spherical over filamentous particles in influenza- and parain-
fluenza virus-infected polarized MDCK cells (Roberts and
Compans, 1998), support the role of actin depolymerization
in bud closure.
Finally, lipid rafts can affect both bud formation and fusion
and fission processes at multiple steps. As indicated earlier,
asymmetry in the lipid bilayer can cause membrane curvature
leading to the formation of buds (Holopainen et al., 2000) and
reduced lipid raft association causes deformed virus particles
(Zhang et al., 2000). Assembly of lipid rafts at the budding
site will affect physical properties of the membrane includ-
ing lipid heterogeneity, lipid–protein interaction, increased
viscosity and rigidity, slow diffusion, etc. The presence of
lipid heterogeneity could cause increased fission and release
of buds. However, a specific role of lipid rafts in bud com-
pletion remains undefined.
6. Release of virus particles
Lastly, after their budding from the host cell, viruses must
be released into the surrounding medium to infect other cells.
With influenza viruses, bud formation and bud closure caus-
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aps4, Nedd4, and other members of the vacuolar protein sort-
ng pathway have been shown to be involved in the budding
rocess (for review, see Freed, 2002, 2003; Luban, 2001;
ornillos et al., 2002; Yap and Stoye, 2003). All of these
ost proteins in some way facilitated the fusion and fission
rocesses in bud release so that any defect in the interaction
f these virus and host components led to defective or in-
omplete virus release, often forming multiple VLPs joined
ogether. However, how these host proteins or their interac-
ions with viral late domains facilitate the process of fusion
nd fission remains unclear. These defective particles were
ot completely filamentous or tubular but exhibited clover
eaf-like or tethered structures (Garrus et al., 2001) suggest-
ng incomplete membrane fusion and fission. Similar struc-
ures representing defective budding by joining of multiple
articles due to incomplete fusion and fission were found in
utant influenza viruses (Hui et al., 2003a) (Fig. 1). It will
e interesting to determine if these particles represent a state
imilar to hemifusion in which only the inner leaflet under-
oes fusion and therefore cannot undergo complete fission
nd release from the host membrane and separation from
ach other (Fig. 2B).
In addition, as indicated earlier, cytoskeletal components,
articularly actin microfilaments, have been shown to con-
ribute to filamentous forms of influenza virus particles
Roberts and Compans, 1998). Microfilaments that bind to
he vRNP may provide outward pushing force in bud forma-
ion. However, if actin is involved in the budding process,
he fusion of membrane at the stalk of the bud and fission
f buds will require disassembly of actin filaments at the last
tage of the budding process. Enhanced release of virus parti-ng pinching off of the virus particle may not be sufficient
o release the virus into the external environment since the
eleased particles may still be attached to the infected host
ell via sialic acid. The data from ts viruses at restrictive
emperature, deletion or mutations of NA gene leading to
he loss of NA enzyme activity as well as inhibitors of NA
learly demonstrate that NA activity is involved in virus re-
ease (Barman et al., 2004; Palese and Compans, 1976; Palese
t al., 1974). The NA removes sialic acid, the receptor for in-
uenza virus, from the membrane glycolipids and glycopro-
eins of both the virus particles and virus-infected cells and
hus prevents self-aggregation of virus particles and reattach-
ent to the virus-infected cell. However, as indicated earlier,
A is not critically required for the infectious cycle in cul-
ured cells provided sialidase is present in the medium (Liu
t al., 1995).
. Role of virus budding in pathogenesis
In a natural setting of viral infection, either the human
r animal host is infected at a very low MOI with relatively
ew virus particles. Therefore, multiple cycles of replication
eading to release of new progeny viruses and infection of
ew host cells by the progeny viruses must be repeated many
imes and are critically required not only for the survival of
he virus and cell-to-cell spread but also for producing the
isease syndrome in the infected host. In most cases, viruses
ust kill, destroy or alter the function of a large number of
ells of a specific organ or tissue before the specific functional
bnormality in the form of a disease syndrome such as pneu-
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monia, hepatitis, or acquired immune deficiency syndrome
(AIDS), etc. is manifested. The site and the nature of budding
can be an important contributory factor in viral pathogenesis
particularly for respiratory viruses like influenza viruses. In-
fluenza viruses bud from the apical surface of polarized ep-
ithelial cells (e.g. bronchial epithelial cells) into the lumen of
lungs and are therefore usually pneumotropic, i.e. restricted
to lungs, and do not cause viremia or invade other internal or-
gans. However, some influenza viruses like fowl plague (H5
or H7) as well as WSN (H1N1) viruses (H1, H5, H7 indicate
the HA subtype specificity of type A influenza viruses) are not
restricted to lungs and produce viremia infecting other inter-
nal organs (pantropism) and cause severe mortality in infected
animals (Mori et al., 1995; Subbarao and Katz, 2000). In hu-
mans, most influenza viruses are pneumotropic and do not
spread to other internal organs. Why the Spanish flu virus of
1918 caused such a devastating pandemic, killing 20–40 mil-
lion people world-wide and affecting young healthy adults,
remains unclear. In addition to pneumonia, some people died
due to massive pulmonary hemorrhage and edema. The 1918
Spanish flu virus, like fowl plague viruses, may have been
pantropic causing viremia and infecting other organs. Why
some influenza viruses are pneumotropic while others are
pantropic and highly virulent is not fully understood. The
severity of viral pathogenesis depends on both viral factors
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remains unknown. The NS1 protein, an interferon antago-
nist, can contribute to virulence in a species-specific manner
(Krug et al., 2003). As indicated earlier, the M gene, encoding
M1 and M2 proteins, can affect virus replication at multiple
stages of the infectious cycle and has a profound effect on
virus virulence. However, the role of the M gene in the viru-
lence of specific virus strains like the 1918 influenza virus is
unknown. Recent studies with M1 mutants have shown that
the M1 gene can have a profound effect on virulence of WSN
virus in mice but no effect on virus replication and growth in
MDCK cells in culture (Hui, Smee and Nayak, unpublished
data). In Sendai virus, the M gene was shown to cause en-
hanced basolateral budding and increased virulence. Sendai
virus mutant F1-R, which exhibited pantropism, possessed
two characteristics: (i) like the H7, H5 HA, ubiquitous cleav-
age of mutant F → F1 + F2 due to the presence of multiple
basic residues and (ii) altered budding from both the apical
and basolateral surface possibly due to mutations in the M
protein which caused disruption of microtubules and polar-
ized transport (Tashiro et al., 1993, 1996). Therefore, altered
budding could be an important contributing factor in the dis-
semination of virus into blood, invasion of internal organs,
pantropism and consequently, higher virulence of a specific
influenza virus strain.
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and host factors including host defense and immunity. Deter-
inants for virulence of influenza viruses are complex and
ultigenic. However, as indicated earlier (see Section 1), one
ingle factor critically required for viral growth and virulence
s cleavability of HA→ HA1 and HA2. Normally, influenza
irus is restricted in lungs because its HA can be cleaved
y tryptase Clara, a serine protease restricted to the lungs
Kido et al., 1999b). However, HAs of H5 and H7 pantropic
vian virus subtypes contain multiple basic amino acids at
he junction of HA1 and HA2 and can be cleaved by furin
nd subtilisin-type enzymes (Horimoto and Kawaoka, 1995),
hich are present ubiquitously. Such viruses can therefore
row in other organs. In addition, the NA of some influenza
iruses like WSN binds and activates plasminogen into plas-
in in the vicinity of HA and the activated plasmin cleaves
A → HA1 + HA2 rendering the virus infectious. There-
ore, WSN virus lacking multiple basic residues in its HA
an grow and multiply in tissues other than lungs. However,
he sequences of HA and NA genes from the 1918 pandemic
uman virus, and predicted HA and NA protein amino acid
equences (Reid et al., 1999, 2000) cannot explain the sever-
ty of its virulence. It is likely that other viral genes are in-
olved in the virulence of 1918 “Spanish” flu viruses (for
eview, see Reid and Taubenberger, 2003; Taubenberger et
l., 2000). The presence of the WSN NA gene alone, which
s responsible for HA cleavage, could not cause pantropism
nd neurovirulence in mice (Ward, 1995). Other WSN genes,
ike M, NS and NA, were required to cause neurovirulence
Schlesinger et al., 1998; Ward, 1996) and therefore were
lso required for viremia and pantropism. The specific func-
ion of M and NS genes in pantropism and neurovirulence. Conclusion
Influenza viruses bud from the plasma membrane, more
pecifically from the apical domain of the plasma membrane
n polarized epithelial cells both in vivo and in tissue cul-
ure. Assembly and morphogenesis of influenza viruses re-
uire the transport of the viral components to the assembly
ite and interaction among the viral components. Further-
ore, influenza viruses bud from the apical plasma mem-
rane and from specific membrane microdomains called lipid
afts present on the plasma membrane. Virus morphogenesis
lso requires an outward membrane curvature at the assem-
ly site leading to bud formation, eventual fusion of the ap-
osing membranes, fission of buds and separation of virus
articles from cellular membranes, and virus release to the
utside environment. These budding processes are active and
nergy-dependent, and are affected by physical factors such
s membrane fluidity and viscosity at the budding site. Elu-
idation of the processes involved in the assembly and mor-
hogenesis of virus particles is critical to understanding virus
rowth and multiplication is therefore crucial in defining vi-
al infectivity, transmission, virulence, tissue tropism, host
pecificity and pathogenesis, and will contribute to an over-
ll understanding of the disease process and progression of
isease including morbidity and mortality of infected hosts.
n addition, the site of budding can also affect virus virulence
nd pathogenesis. In this review, we have discussed the crit-
cal steps required for the assembly and morphogenesis of
nfluenza viruses, i.e. directing the viral components to the
ssembly site and interactions among the viral components,
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bud formation, closure of buds and release of virus particles.
However, virus budding is among the least understood pro-
cesses in virus biology and requires concerted action by a
number of viral and host factors. Little is known about the
host factors involved in influenza virus budding. A better un-
derstanding of viral replication and morphogenesis will fa-
cilitate the development of novel therapeutic agents capable
of interfering with these critical steps in viral multiplication,
pathogenesis and disease progression.
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